Showing results (201-210 of 1,016) with videos related to
Sort By:
Pageof 102
Journal of Translational Medicine|December 9, 2010
Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade culturesGiuseppina Bonanno, Paola Iudicone, Andrea Mariotti, et al.International Journal of Molecular Sciences|November 13, 2020
FAK Signaling in RhabdomyosarcomaClara Perrone, Silvia Pomella, Matteo Cassandri, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15Sergio Rutella, Giuseppina Bonanno, Maria Marone, et al.Experimental Hematology|March 8, 2002
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemiaFederica Sorà, Andrea Antinori, Nicola Piccirillo, et al.Cell Death and Differentiation|August 23, 2019
HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagyFlavie Strappazzon, Anthea Di Rita, Angelo Peschiaroli, et al.Plos One|March 19, 2014
Oligophrenin-1 (OPHN1), a gene involved in X-linked intellectual disability, undergoes RNA editing and alternative splicing during human brain developmentSabina Barresi, Sara Tomaselli, Alekos Athanasiadis, et al.Seminars in Hematology|December 1, 2020
NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdlesSimona Caruso, Biagio De Angelis, Simona Carlomagno, et al.Haematologica|April 12, 2005
Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipientsGiuseppe Gerna, Daniele Lilleri, Marco Zecca, et al.Advances in Therapy|March 27, 2025
Impact of Different Definitions of Vaso-Occlusion on Efficacy Assessments in Sickle Cell Disease Clinical TrialsHaydar Frangoul, Franco Locatelli, Michael J Eckrich, et al.Frontiers in Immunology|February 28, 2014
Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesCristina Bottino, Alessandra Dondero, Francesca Bellora, et al.Pageof 102